-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A study led by Xiujun Cai screened the whole genome of hepatoma cells (HepG2) under sorafenib treatment by the CRISPR/cas9 system, and screened the dominant gene KEAP1 for sorafenib resistance
Using bioinformatics tools and experimental validation, such as qPCR, FGF21 was found to be the most relevant downstream molecule of Nrf2 in the context of sorafenib resistance in hepatocellular carcinoma
The research was published in the journal Science China Life Sciences
Provided by Scientific China Press